- Home
- ATAI vs CCSI Comparison
ATAI vs CCSI Comparison
Compare ATAI & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- CCSI
- Stock Information
- Founded
- ATAI 2018
- CCSI 2021
- Country
- ATAI Germany
- CCSI United States
- Employees
- ATAI N/A
- CCSI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- ATAI Health Care
- CCSI Technology
- Exchange
- ATAI Nasdaq
- CCSI Nasdaq
- Market Cap
- ATAI 444.7M
- CCSI 450.6M
- IPO Year
- ATAI 2021
- CCSI N/A
- Fundamental
- Price
- ATAI $4.66
- CCSI $28.43
- Analyst Decision
- ATAI Strong Buy
- CCSI Hold
- Analyst Count
- ATAI 3
- CCSI 5
- Target Price
- ATAI $13.33
- CCSI $27.20
- AVG Volume (30 Days)
- ATAI 5.2M
- CCSI 115.8K
- Earning Date
- ATAI 08-14-2025
- CCSI 11-06-2025
- Dividend Yield
- ATAI N/A
- CCSI N/A
- EPS Growth
- ATAI N/A
- CCSI N/A
- EPS
- ATAI N/A
- CCSI 4.15
- Revenue
- ATAI $2,309,000.00
- CCSI $349,595,000.00
- Revenue This Year
- ATAI $661.36
- CCSI $1.55
- Revenue Next Year
- ATAI N/A
- CCSI $1.10
- P/E Ratio
- ATAI N/A
- CCSI $6.79
- Revenue Growth
- ATAI 510.85
- CCSI N/A
- 52 Week Low
- ATAI $1.03
- CCSI $17.84
- 52 Week High
- ATAI $5.34
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- ATAI 58.92
- CCSI 68.99
- Support Level
- ATAI $4.50
- CCSI $26.82
- Resistance Level
- ATAI $4.99
- CCSI $27.82
- Average True Range (ATR)
- ATAI 0.35
- CCSI 0.69
- MACD
- ATAI -0.04
- CCSI 0.03
- Stochastic Oscillator
- ATAI 35.87
- CCSI 94.76
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.